Whitepaper

New Market Opportunities with Curcumin C3 Reduct^®

Sabinsa has developed C3 Reduct^®, a curcuminoids-based ingredient that has been scientifically shown to boost organ health and deliver a range of other targeted functionalities. This makes it
ideal to help manufacturers meet consumer health and wellness expectations – and tap new opportunities in growing markets such as sports nutrition.

Integrating C3 Reduct^® in New Product Development

Sabinsa has developed Curcumin C3 Reduct^®, the only reductive metabolites of curcuminoids on the market to have been approved as a Novel Food by the European Food Safety Authority (EFSA). Easy to integrate into existing production processes and with the concentrated benefits of curcumin, C3 Reduct^® has been shown to boost organ health and deliver a range of other targeted functionalities.